<unk> , sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. It is not indicated for the preventive treatment of migraine.<unk>  is a small-molecule calcitonin gene-related peptide receptor antagonist. It is the first drug in this class approved for the acute treatment of migraine. The most common side effects are nausea, tiredness and dry mouth.<unk>  is contraindicated for co-administration with strong CYP3A4 inhibitors.
Ubrogepant
Suvorexant
Rimegepant
Tasimelteon
Icatibant
Patiromer
Veristrat
Bocasan